Matthew Milowsky, MD (IMAGE)

UNC Lineberger Comprehensive Cancer Center

Matthew Milowsky, MD

Caption

“Optimal management of muscle-invasive bladder cancer is a huge unmet need,” said UNC Lineberger’s Matthew Milowsky, MD. “We think that the combination treatment used in our trial may improve outcomes compared with chemotherapy alone, with the aim of ridding micro-metastatic disease so that even a modest improvement in response rates translates to higher cure rates.”

Credit

UNC Lineberger Comprehensive Cancer Center

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.